author-photo

Philippe Huot-Marchand

9

Papers

83

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

2020 RMD Open
Show All
- Source
- Cite
- Save
Citations (2)
Effectiveness of the Crizotinib Therapeutic Management Guide in Communicating Risks, and Recommended Actions to Minimize Risks, Among Physicians Prescribing Crizotinib in Europe

2018 Pharmaceutical medicine
Show All
- Source
- Cite
- Save
Citations (7)
Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (49)
Observational study of ferric carboxymaltose in France (OncoFer; interim analysis).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France

2016 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (20)
A novel oncologist-led BRCA1/2 germline mutation (gBRCAm) testing and counselling model for patients with ovarian cancer: Interim results from the ENGAGE (NCT02406235) study

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Observational study of ferric carboxymaltose (FCM) in france (oncofer study; interim analysis)

2013 Value in Health
Show All
- Source
- Cite
- Save
Citations (1)